![Stephen Hill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 310 103 $ al 31/05/2026
Stephen Hill is currently Chief Operating Officer at Lyell Immunopharma, Inc. since 2021.
Formerly, Mr. Hill was Vice President-Bulk Manufacturing at Amgen, Inc. and SVP & Head-Global Biologics Operations at AstraZeneca PLC from 2018 to 2019.
Education includes undergraduate and MBA degrees from the University of Washington.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LYELL IMMUNOPHARMA, INC. 0,08 % | 11/05/2026 | 17.894 ( 0,08 % ) | 310 103 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Director de Operaciones | 01/11/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/06/2019 |
| AMGEN INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
